Comparing two heart failure medications in ICD patients
Treatments studied
Part of Heart & circulation clinical trials.
This trial compares two beta-blocker medications, carvedilol and metoprolol succinate, to see which one works better for people with heart failure who have an implantable cardioverter defibrillator (ICD). If you are currently taking metoprolol succinate, you may be able to switch to carvedilol and help researchers find the best treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have an ICD placed to prevent sudden cardiac arrest due to heart failure, and it has remote monitoring.
- You are currently taking metoprolol succinate for heart failure and are willing to switch to carvedilol.
- Your heart's pumping ability (LVEF) has been below 50% in the last 12 months.
- You have not had a bad reaction to carvedilol before.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a low dose of metoprolol (a beta-blocker) is safe and helpful for people who have both heart failure with reduced pumping ability and COPD. The goal is to see if it can improve heart function without worsening breathing problems.
This trial tests whether combining modern heart failure medications with an implantable defibrillator (ICD) can reduce the risk of dangerous heart rhythms and improve survival in people with dilated cardiomyopathy. It focuses on those with a weak heart pump and specific scarring seen on MRI.
This trial compares two types of “left-side” heart pacing to see which one works better in people with weak heart pumping. It may help guide the best pacing choice for improving heart function and symptoms.
This trial tests whether carvedilol and metoprolol succinate work similarly in people with heart failure with reduced pumping ability. If you already need a beta-blocker, your doctor may compare which one fits better for your situation.
This trial tests whether starting the heart failure medication carvedilol early, along with standard monitoring, can help people in cardiogenic shock (when the heart can't pump enough blood) due to a weak heart muscle. It aims to see if earlier treatment improves outcomes.
This trial tests which heart medications work best for older adults who have stable angina (predictable chest pain) and multiple other long-term health problems. You may be asked to start or adjust medications and attend regular follow-up visits to see which approach controls symptoms and outcomes.
Hear when a new Sudden Cardiac Death trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.